Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Probi AB (publ)
  6. News
  7. Summary
    PROB   SE0001280355

PROBI AB (PUBL)

(PROB)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Probi : Presentation of Probi's Q2 report 2021

07/13/2021 | 02:35am EDT
Press Release - 13 Jul 2021 Presentation of Probi's Q2 report 2021

Probi's report for the second quarter 2021 will be published on Friday, 16 July at 8.00 a.m. CET.

In conjunction with this, analysts, investors and media are invited to an audiocast telephone conference on the same day at 10.00 a.m., where CEO Tom Rönnlund and CFO Henrik Lundkvist will present and comment on the report. The presentation and presentation material can be obtained via www.probi.com or https://tv.streamfabriken.com/probi-q1-2021

The presentation can also be followed via a telephone conference on the following telephone number:
Sweden: +46 8 50 55 83 53
UK: +44 33 33 00 92 72
US: +1 63 19 13 14 22
PIN: 39394326#

After the presentation, conference participants will be able to ask questions. Questions can also be asked via the audiocast.

An on-demand version of the presentation will be available at the address given above following the presentation.

For further information, please contact:

Henrik Lundkvist, CFO, Probi, phone +46 46 286 89 41, E-mail: henrik.lundkvist@probi.com

ABOUT PROBI
Probi® is a global company focused exclusively on researching, manufacturing, and delivering probiotics for supplements and functional food. The company is an expert in managing stable, live bacteria from research through every stage of the manufacturing process and are dedicated to making the health-enhancing benefits of probiotics available to people everywhere. Since the company was founded in 1991 at Lund University in Sweden, Probi has expanded its operations to more than 40 markets and holds more than 400 patents worldwide. Probi had sales of SEK 717 m in 2020. Probi's shares are listed on Nasdaq Stockholm, Mid-cap. and there were around 4,000 shareholders on December 31, 2020.

PDF

Disclaimer

Probi AB published this content on 13 July 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 July 2021 06:34:03 UTC.


© Publicnow 2021
All news about PROBI AB (PUBL)
08/31PROBI : Good tolerance in newborns of two specific probiotic...
PU
08/31PROBI : Good tolerance in newborns of two specific probiotic strains from Probi
AQ
08/31PROBI : Changes to Probi's Nomination Committee
PU
08/31PROBI : Changes to Probi's Nomination Committee
AQ
08/31Probi AB Announces Changes to Nomination Committee
CI
08/18SenzaGen appoints Peter Nählstedt as new CEO
AQ
07/16Probi Seeks Acquisitions
CI
07/16Q2 2021 : Probi enters new strategic partnerships
AQ
07/16Probi AB Publ Reports Earnings Results for the Second Quarter Ended June 30, ..
CI
07/13PROBI : Presentation of Probi's Q2 report 2021
PU
More news
Analyst Recommendations on PROBI AB (PUBL)
More recommendations
Financials
Sales 2021 712 M 82,0 M 82,0 M
Net income 2021 95,0 M 10,9 M 10,9 M
Net cash 2021 251 M 28,9 M 28,9 M
P/E ratio 2021 50,7x
Yield 2021 0,28%
Capitalization 4 831 M 556 M 557 M
EV / Sales 2021 6,43x
EV / Sales 2022 5,31x
Nbr of Employees -
Free-Float 35,6%
Chart PROBI AB (PUBL)
Duration : Period :
Probi AB (publ) Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PROBI AB (PUBL)
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 0
Last Close Price 424,00 SEK
Average target price 505,00 SEK
Spread / Average Target 19,1%
EPS Revisions
Managers and Directors
Tom Juhani Rönnlund Chief Executive Officer
Henrik Lundkvist Chief Financial Officer
Jean-Yves Parisot Chairman
Niklas Brandt Vice President-Information Technology
Niklas Larsson Lead Scientific Affairs
Sector and Competitors
1st jan.Capi. (M$)
PROBI AB (PUBL)0.47%556
NESTLÉ S.A.9.71%337 968
MONDELEZ INTERNATIONAL, INC.4.22%85 183
YIHAI KERRY ARAWANA HOLDINGS CO., LTD-36.95%57 269
DANONE10.34%45 317
THE KRAFT HEINZ COMPANY5.45%44 715